A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 1 642,78 kr, with a 24-hour trading volume of 4,74B kr. The asset's market cap is 2,54T kr, after moving 0.22% in the last day.
Tokenized AstraZeneca PLC is trading at 920,62 kr, with a tokenized market cap of 521,23M kr and a 24-hour trading volume of 8,1M kr. The tokenized asset has moved -0.45% in the past 24 hours.